Lorenz Urner

Lorenz Urner is a Senior Scientist at Roche since October 2020, previously holding a position as a Scientist in Medicinal Chemistry at The Janssen Pharmaceutical Companies of Johnson & Johnson from March to August 2020. Prior experience includes a Postdoctoral Researcher role at the University of California, Los Angeles, focusing on the development of brain-penetrant EGFR tyrosine kinase inhibitors from June 2017 to February 2020, and a Group Leader R&D position at Bachem from May 2015 to May 2017. Additional experience includes serving as a Research Assistant at UniversitätsSpital Zürich in early 2015, where involvement included developing experimental setups and automated data processing software for clinical trials. Lorenz Urner earned a Dr. sc. ETH in Organic Chemistry from ETH Zürich between 2010 and 2014, and also holds a Master's Degree in Interdisciplinary Natural Sciences from ETH Zürich, completed in 2009, with time spent at Stanford University and the University of Cambridge.